Cargando…
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy
BACKGROUND: Do colorectal cancer patients with hyperbilirubinemia and liver metastases benefit from chemotherapy? METHODS/RESULTS: This study entailed a review of 3,019 consecutive patients with colorectal cancer. Within this cohort, 20 met the study’s a priori selection criteria, which included a n...
Autores principales: | Walia, Tamana, Quevedo, J Fernando, Hobday, Timothy J, Croghan, Gary, Jatoi, Aminah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643116/ https://www.ncbi.nlm.nih.gov/pubmed/19337442 |
Ejemplares similares
-
Pemetrexed for Ovarian Cancer: A Systematic Review of the Published Literature and a Consecutive Series of Patients Treated in a Nonclinical Trial Setting
por: Egloff, Heidi, et al.
Publicado: (2014) -
Clinical, histopathological and immunohistochemical features of brain metastases originating in colorectal cancer: a series of 27 consecutive cases
por: Scripcariu, Viorel, et al.
Publicado: (2020) -
What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes
por: Ehret, Christopher, et al.
Publicado: (2023) -
Are 5–7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series
por: Griffin, Benjamin R., et al.
Publicado: (2013) -
Hepatic epithelioid hemangioendothelioma: case series of a rare vascular tumor mimicking metastases
por: Din, Nasir Ud, et al.
Publicado: (2020)